Skip to main content
. 2020 Nov;112(6):5324–5330. doi: 10.1016/j.ygeno.2020.10.032

Fig. 3.

Fig. 3

Comparison of cancer NGS assay gene content from commercial and healthcare providers with an objectively defined and clinically tiered set of cancer driver genes.